Positions

Selected Publications

Academic Article

Year Title Altmetric
2010 Dynamics of the Drosophila circadian clock: theoretical anti-jitter network and controlled chaos.PLoS ONE.  5:e11207. 2010
2010 Malignant astrocytomas: a system disease.Archives of Neurology -Chigago-.  67:353-355. 2010
2009 Mathematical model of the Drosophila circadian clock: loop regulation and transcriptional integration.Biophysical Journal.  97:2399-2408. 2009

Research Overview

  • Mathematical Modeling Cancer Biology Dynamical Systems Network Theory
  • Principal Investigator On

  • Private Grant  awarded by Sanofi US Services Inc 2013 - 2017
  • Private Grant  awarded by NOVOCURE (ISRAEL) LTD 2013 - 2016
  • Private Grant  awarded by NOVOCURE, INC. 2014 - 2016
  • Minimal-Perturbation Dynamic Control of the Melanoma Gene Regulatory Network  awarded by UNIVERSITY OF ILLINOIS (CHICAGO) 2010 - 2015
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2012 - 2014
  • Private Grant  awarded by Sanofi US Services Inc 2010 - 2013
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2010 - 2013
  • Investigator On

  • Private Grant  awarded by IMMUNOCELLULAR THERAPEUTICS 2016 - 2021
  • Private Grant  awarded by BOSTON BIOMEDICAL, INC. 2018 - 2020
  • Individualized Screening trial of Innovative Glioblastoma Therapy (INSIGhT)  awarded by Dana-Farber Cancer Institute 2018 - 2020
  • Phase I Study of MK-1775 with Radiation and Temozolomide In Patients with Newly Diagnosed Glioblastoma and Evaluation of lntratumoral Drug Distribution in Patients with Recurrent Glioblastoma  awarded by Johns Hopkins University 2013 - 2019
  • Private Grant  awarded by ABBVIE INC 2017 - 2019
  • Private Grant  awarded by ABBVIE INC 2017 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2019
  • Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients with Recurrent High Grade Glioma  awarded by Johns Hopkins University 2018 - 2019
  • A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination with Anti-PD-1 in Patients with Recurrent GBM  awarded by Johns Hopkins University 2016 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2017 - 2019
  • Private Grant  awarded by VASCULAR BIOGENICS LTD 2016 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2017 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2014 - 2019
  • Private Grant  awarded by ORBUS THERAPEUTICS, INC. 2016 - 2018
  • A Phase I Open Label Safety Study to Evaluate the Pharmacokinetic Profile and Tolerance of Mibefradil Dose Finding in Subjects with Recurrent High-Grade Glioma Undergoing Standard. Repeated Temozolomide Treatment (TAU-2010-1)  awarded by Johns Hopkins University 2013 - 2018
  • Private Grant  awarded by ARCHER BIOSCIENCES 2013 - 2018
  • Single-arm, Open-label Phase II Efficacy Study of First-in-class HIF2-Alpha Inhibitor, PT2385, for Patients with Recurrent Glioblastoma  awarded by Johns Hopkins University 2017 - 2018
  • Phase I Study to Determine the Safety and Tolerability of the Oral Microtubule Destabilizer BAL 101553 in Combination with Standard Radiation in Patients with MGMT Promoter Unmethylated Newly Diagnosed Glioblastoma  awarded by Johns Hopkins University 2017 - 2018
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2014 - 2018
  • Private Grant  awarded by STEMLINE THERAPEUTICS INC 2014 - 2018
  • Private Grant  awarded by NATIVIS, INC. 2015 - 2018
  • Private Grant  awarded by ABBVIE INC 2015 - 2018
  • Phase II Study of TRC102 in Combination with Temozolomide for Recurrent Glioblastoma  awarded by Johns Hopkins University 2016 - 2018
  • Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients with Recurrent High Grade Glioma (ABTC 1401)  awarded by Johns Hopkins University 2015 - 2018
  • Private Grant  awarded by IMMUNOCELLULAR THERAPEUTICS 2015 - 2017
  • Contemporary Therapeutics for Anaplastic Gliomas  awarded by National Cancer Institute/NIH/DHHS 2011 - 2017
  • Pilot Study of MLN0128 in Preoperative Recurrent Glioblastoma (GBM) Patients  awarded by Johns Hopkins University 2014 - 2016
  • Contemporary Therapeutics for Anaplastic Gliomas - Brain Tumor Tissue Core  awarded by National Cancer Institute/NIH/DHHS 2011 - 2016
  • Private Grant  awarded by ARCHER BIOSCIENCES 2014 - 2015
  • A Phase lb Study of Cediranib in Combination with Cilengitide in Patients with Recurrent Glioblastoma  awarded by Johns Hopkins University 2010 - 2014
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2013 - 2014
  • ACRIN 6684: Phase II Assessment of Tumor Hypoxia in Glioblastoma Using FMISO with PET and MRI (R09-185)  awarded by American College of Radiology 2010 - 2014
  • Private Grant  awarded by EMD SERONO 2009 - 2013
  • Private Grant  awarded by EMD SERONO 2009 - 2013
  • Education And Training

  • Doctor of Medicine, Foreign University
  • Doctor of Philosophy in Mathematics, University of Illinois System : Chicago
  • Full Name

  • Hassan Fathallah-Shaykh
  • Blazerid

  • hfathall